ArtNr |
HY-12694-100mg |
Hersteller |
MedChem Express
|
CAS-Nr. |
179474-85-2 |
Menge |
100 mg |
Quantity options |
100 mg
10 mM/1 mL
10 mg
200 mg
50 mg
5 mg
|
Kategorie |
|
Typ |
Inhibitors |
Clon |
N/A |
Specific against |
other |
Purity |
99.95 |
Formula |
C22H32ClN3O7 |
Citations |
[1]Briejer MR, et al. The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol. 2001 Jun 29;423(1):71-83. [2]Johnson DE, et al. The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations. J Pharmacol Exp Ther. 2012 Jun;341(3):681-91. [3]Wang Y, et al. Prucalopride might improve intestinal motility by promoting the regeneration of the enteric nervous system in diabetic rats. Int J Mol Med. 2022 Jul;50(1):87. [4]Chen M, et al. Prucalopride inhibits lung cancer cell proliferation, invasion, and migration through blocking of the PI3K/AKT/mTor signaling pathway. Hum Exp Toxicol. 2020 Feb;39(2):173-181. |
Smiles |
O=C(O)CCC(O)=O.O=C(C1=C(OCC2)C2=C(N)C(Cl)=C1)NC3CCN(CCCOC)CC3 |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
R-108512 |
Versandbedingung |
Raumtemperatur |
Lieferbar |
|
Manufacturer - Type |
Reference compound |
Manufacturer - Targets |
5-HT Receptor; Apoptosis; Autophagy |
Shipping Temperature |
Room Temperature |
Storage Conditions |
4°C (Powder, sealed storage, away from moisture) |
Molecular Weight |
485.96 |
Product Description |
Prucalopride succinate is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively. Prucalopride succinate improves intestinal motility by promoting regeneration of the intestinal nervous system in rats. Prucalopride succinate also shows anticancer activity by blocking of the PI3K/AKT/mTor signaling pathway. Prucalopride succinate can be used in studies of chronic constipation, pseudo-intestinal obstruction and cancer[1][2][3][4]. |
Manufacturer - Research Area |
Cancer; Metabolic Disease |
Solubility |
DMSO : 50 mg/mL (ultrasonic)|H2O : ≥ 20 mg/mL |
Manufacturer - Pathway |
Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling |
Isoform |
5-HT4 Receptor |
Clinical information |
Launched |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.